Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2024-04-04
2025-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Mirror Therapy Rehabilitation Device to Conventional Mirror Therapy
NCT06842888
Comparing Unimanual and Bimanual Mirror Therapy for Upper Limb Recovery Post Stroke
NCT02780440
Encouragement-induced Movement Therapy in Daily Life
NCT03294187
Mirror Therapy: Effects on Functional Recuperation of Severe Upper Limb Paresis After Stroke
NCT02949609
Use of Tendon Vibration and Mirror for the Improvement of Upper Limb Function and Pain Reduction
NCT01010607
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional Therapy Group
Participants in this group with train using Mirror Therapy (MT), the current standard of care.
Mirror Therapy
Current standard of care using MT.
Miraπ Group
Participants in this group will train with the Miraπ device.
Miraπ
This device has tiny sensors that measure the movement of the healthy fingers and tiny motors that move the affected fingers of the patient.
The device is connected to a specially designed finger mechanism that moves the affected fingers of the patient. This opening mechanism is designed in a way that it prevents the fingers from being forced into any hurting position. If the patient moves the healthy fingers during training, also the fingers of the affected hand are moved by the device at the same time. This creates the effect of mirror therapy for the brain as the patient can see both hands moving.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Miraπ
This device has tiny sensors that measure the movement of the healthy fingers and tiny motors that move the affected fingers of the patient.
The device is connected to a specially designed finger mechanism that moves the affected fingers of the patient. This opening mechanism is designed in a way that it prevents the fingers from being forced into any hurting position. If the patient moves the healthy fingers during training, also the fingers of the affected hand are moved by the device at the same time. This creates the effect of mirror therapy for the brain as the patient can see both hands moving.
Mirror Therapy
Current standard of care using MT.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants with paralysis or motor function problems of only one hand.
* Participants spasticity of the affected hand ( as assessed by by the occupational therapist)
* Participants need mirror therapy because of their health condition.
* Participants are able to memorize easy tasks, and able to follow instructions e.g., moving the healthy fingers.
Exclusion Criteria
* Participants who are not able to memorize easy tasks, e.g., moving the healthy fingers.
* Participants with spasticity of the affected hand ( as assed by the occupational therapist)
* Vulnerable populations
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Management Center Innsbruck (MCI), Austria
UNKNOWN
Yale School of Engineering Center for Engineering Innovation and Design
UNKNOWN
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rummana Aslam, MD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale New Haven Health Inpatient Rehabilitation Unit, Bridgeport Hospital
Bridgeport, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
000
Identifier Type: OTHER
Identifier Source: secondary_id
2000037049
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.